Managing High Blood Pressure In Type 2 Diabetes Sufferers Could Save Lives

September 10, 1998

High blood pressure has been known to be a "bad companion" of diabetes for many years. This week's BMJ publishes three papers which are based on a long running study conducted by the United Kingdom Prospective Diabetes Study Group and it is hoped that the results will now offer clinicians some effective treatment options for diabetes sufferers with high blood pressure.

The research group, led by Professor Robert Turner, from the Radcliffe Infirmary in Oxford, found that by lowering blood pressure in non-insulin dependent (type 2) diabetes patients in the long term, clinicians can diminish diabetic complications by a quarter (24 per cent) and reduce diabetes related deaths (usually due to heart attack or stroke) by a third (32 per cent). The Group has shown that Beta blockers or angiotensin converting enzyme inhibitors are equally effective in managing high blood pressure in type 2 diabetes patients.

The UK Prospective Diabetes Study Group also examined the cost effectiveness of managing blood pressure in diabetes patients and they found that tight control of blood pressure substantially reduced costs to the health service, by reducing complications in later life. Furthermore such treatment seems to give patients a longer life expectancy with fewer complications.

The authors conclude that on both clinical and economic grounds the use of a policy of tight control of blood pressure in hypertensive patients with non-insulin dependent diabetes is justified.

Contact:

Gill Sanders, Press Office, University of Oxford, Oxford


Dawn Duncan or James Yeandel, Press Office, Medical Research Council, London
-end-


BMJ

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.